Polyomavirus neutralizing antibodies
US10654914B2 · kind B2 · utility
5Cited by
4References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 2018 |
| Grant date | May 19, 2020 |
| Priority date | — |
| Expiry date | Nov 7, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.